CARBAMAZEPINE
- Product NDC
- 71335-0462
- 11-digit product format
- 713350462
- Labeler code
- 71335
- Product ID
- 71335-0462_1a2949a1-23b9-4617-8448-fa071cbcd648
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CARBAMAZEPINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA077272
- Marketing category
- ANDA
- Marketing start
- 2009-10-23
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0462-1 | 71335046201 | 30 TABLET in 1 BOTTLE (71335-0462-1) | 30 tablet | 2020-05-13 | 0000-00-00 | No | No | Current |
| 71335-0462-2 | 71335046202 | 60 TABLET in 1 BOTTLE (71335-0462-2) | 60 tablet | 2019-10-01 | 0000-00-00 | No | No | Current |
| 71335-0462-3 | 71335046203 | 90 TABLET in 1 BOTTLE (71335-0462-3) | 90 tablet | 2022-03-09 | 0000-00-00 | No | No | Current |
| 71335-0462-4 | 71335046204 | 120 TABLET in 1 BOTTLE (71335-0462-4) | 120 tablet | 2021-12-27 | 0000-00-00 | No | No | Current |
| 71335-0462-5 | 71335046205 | 240 TABLET in 1 BOTTLE (71335-0462-5) | 240 tablet | 2021-12-27 | 0000-00-00 | No | No | Current |
| 71335-0462-6 | 71335046206 | 180 TABLET in 1 BOTTLE (71335-0462-6) | 180 tablet | 2021-12-27 | 0000-00-00 | No | No | Current |